The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 07, 2021

Filed:

Jun. 22, 2017
Applicants:

Max-planck-gesellschaft Zur Förderung Der Wissenschaften E.v., Munich, DE;

Vaxxilon Ag, Reinach, CH;

Inventors:

Peter H. Seeberger, Kleinmachnow, DE;

Claney Lebev Pereira, Berlin, DE;

Madhu Emmadi, Berlin, DE;

Sharavathi Guddehalli Parameswarappa, Berlin, DE;

Adam Calow, Bristol, GB;

Petra Menova, Prague, CZ;

Marilda Lisboa, Berlin, DE;

Christopher Martin, Tuttlingen, DE;

Benjamin Schumann, Berlin, DE;

Fei-Fei Xu, Berlin, DE;

Naeem Khan, Berlin-Britz, DE;

Paulina Kaplonek, Berlin, DE;

Lennart Lykke, Copenhagen, DK;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/09 (2006.01); A61P 31/04 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/092 (2013.01); A61P 31/04 (2018.01); A61K 2039/55505 (2013.01); A61K 2039/6037 (2013.01); A61K 2039/62 (2013.01);
Abstract

The present invention relates to immunogenic compositions comprising a conjugate of a saccharide fromserotype 8 and a carrier protein, and a mixture consisting of capsular polysaccharides fromserotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F individually conjugated to CRMcarrier protein, or a mixture consisting of capsular polysaccharides fromserotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F individually conjugated to a carrier protein, wherein the capsular polysaccharides fromserotypes 1, 4, 5, 6B, 7F, 9V, 14, and 23F are individually conjugated to protein D, the capsular polysaccharide fromserotype 18C is conjugated to tetanus toxoid and the capsular polysaccharide fromserotype 19F is conjugated to diphtheria toxoid. Said compositions are useful for the prevention and/or treatment of diseases caused by


Find Patent Forward Citations

Loading…